Human Genome Epidemiology Literature Finder
Cancer
Records 1 - 30 (of 3440 Records) |
Query Trace: Prostate Cancer[original query] |
---|
Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis. Targeted oncology 2023 12 . Brigida Anna Maiorano, Ugo De Giorgi, Elena Verzoni, Evaristo Maiello, Giuseppe Procopio, Vincenza Conteduca, Massimo Di Maio, |
Toenail zinc and risk of prostate cancer in the MCC-Spain case-control study. Environmental research 2023 12 245 118065. Enrique Gutiérrez-González, Roberto Pastor-Barriuso, Adela Castelló, Gemma Castaño-Vinyals, Nerea Fernández de Larrea-Baz, Trinidad Dierssen-Sotos, José Juan Jiménez-Moleón, Ana Molina-Barceló, Guillermo Fernández-Tardón, Ángela Zumel-Marne, Víctor Moreno, José Luis Gómez-Ariza, M Ángeles Sierra, Tamara García-Barrera, Ana Espinosa, Elena Plans-Beriso, Inés Gómez-Acebo, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Beatriz Pérez-Góm |
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice. Japanese journal of clinical oncology 2023 12 . Shigekatsu Maekawa, Ryo Takata, Kie Sekiguchi, Masahiro Kagabu, Moe Toyoshima, Shinji Tamada, Kenta Takahashi, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Jun Sugimura, Takaya Abe, Tsukasa Baba, Wataru Oba |
SNPs-Panel Polymorphism Variations in GHRL and GHSR Genes Are Not Associated with Prostate Cancer. Biomedicines 2023 12 11 (12): . Nesrine Merabet, Nicolas Ramoz, Amel Boulmaiz, Asma Bourefis, Maroua Benabdelkrim, Omar Djeffal, Emmanuel Moyse, Virginie Tolle, Hajira Berredj |
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 12 JCO2301868. Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzm |
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-?2 levels in metastatic colorectal cancer patients (Alliance). medRxiv : the preprint server for health sciences 2023 12 . Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O'Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L McLeod, Mark J Ratain, Andrew B Nixon, Federico Innocenti, Kouros Owz |
Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation. Pathology oncology research : POR 2023 12 29 1611343. Caixin Zhang, Yong Jia, Qingnuan Ko |
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer. Research square 2023 12 . Jyotsna Batra, Janaththani Panchadsaram, Gregor Tevz, Achala Fernando, Adil Malik, Anja Rockstroh, Thomas Kryza, Carina Walpole, Leire Moya, Melanie Lehman, Colleen Nelson, The Australian Prostate Cancer BioResource, The Practical Consortium, Srilakshmi Sriniva, Judith Clemen |
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. European urology oncology 2023 12 . Jacob J Orme, Fadi Taza, Navonil De Sarkar, Alok K Tewari, Syed Arsalan Naqvi, Irbaz B Riaz, Daniel S Childs, Noha Omar, Nabil Adra, Ryan Ashkar, Heather H Cheng, Michael T Schweizer, Alexandra O Sokolova, Neeraj Agarwal, Pedro Barata, Oliver Sartor, Diogo Bastos, Oren Smaletz, Jacob E Berchuck, Heather McClure, Mary-Ellen Taplin, Rahul Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Niven Mehra, Peter S Nelson, Justin Hwang, Scott M Dehm, Qian Shi, Zoe Fleischmann, Ethan S Sokol, Andrew Elliott, Haojie Huang, Alan Bryce, Catherine H Marshall, Emmanuel S Antonarak |
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in oncology 2024 4 14 1381134. Michael C Repka, Tamir Sholklapper, Alan L Zwart, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T Collins, Deepak Kumar, Simeng Suy, Ryan A Hankins, Amar U Kishan, Sean P Colli |
Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary-Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 4 100489. Susan Prendeville, Harpreet Kaur, Shervin Ansari, Shifaa Alqaqa, Tracy L Stockley, Katherine Lajkosz, Theodorus van der Kwast, Carol C Cheung, Shamini Selvaraj |
Genomic ancestry and cancer among Latin Americans. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales, Claudio Martín, Sandra Franco, Luis Raez, Christian Rolfo, Natalia Sánchez, Andrés Felipe Cardo |
Identification and validation of a novel anoikis-related prognostic model for prostate cancer. Molecular genetics & genomic medicine 2024 4 12 (4): e2419. Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Fe |
Exploration of vitamin D metabolic activity-related biological effects and corresponding therapeutic targets in prostate cancer. Nutrition & metabolism 2024 4 21 (1): 17. Lei Ding, Yong Wang, Zhentao Tang, Chenbo Ni, Qian Zhang, Qidi Zhai, Chao Liang, Jie |
The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities. Scientific reports 2024 4 14 (1): 7706. Ruotian Huang, M S Riana Bornman, Phillip D Stricker, Ilma Simoni Brum, Shingai B A Mutambirwa, Weerachai Jaratlerdsiri, Vanessa M Hay |
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer. The Journal of urology 2024 4 101097JU0000000000003927. Florian Rumpf, Anna Plym, Jane B Vaselkiv, Kathryn L Penney, Mark A Preston, Adam S Kibel, Lorelei A Mucci, Keyan Sala |
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations. Diagnostic pathology 2024 1 19 (1): 9. Anne Vogel, Anna Haupts, Michael Kloth, Wilfried Roth, Nils Hartma |
ER-positive and BRCA2-mutated breast cancer: a literature review. European journal of medical research 2024 1 29 (1): 30. Pu-Chun Li, Yi-Fan Zhu, Wen-Ming Cao, Bei |
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. European urology oncology 2024 1 . Olivier Cussenot, Kirsten M Timms, Emmanuel Perrot, Pascal Blanchet, Laurent Brureau, Cara Solimeno, Gaelle Fromont, Eva Comperat, Geraldine Cancel-Tass |
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World journal of clinical cases 2024 1 12 (1): 32-41. Zhen Song, Qi Zhou, Jiang-Lei Zhang, Jun Ouyang, Zhi-Yu Zha |
Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer. Experimental & molecular medicine 2024 1 . Jeesoo Chae, Seung-Hyun Jung, Eun Ji Choi, Jae Woong Kim, Na Yung Kim, Sung Won Moon, Ji Youl Lee, Yeun-Jun Chung, Sug Hyung L |
Integrated analysis identifies GABRB3 as a biomarker in prostate cancer. BMC medical genomics 2024 1 17 (1): 41. Jun-Yan Chen, Chi-Fen Chang, Shu-Pin Huang, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Jiun-Hung Geng, Chia-Yang Li, Te-Ling Lu, Bo-Ying B |
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence. Clinical genitourinary cancer 2024 1 . Francesco Ditonno, Alberto Bianchi, Sarah Malandra, Antonio Benito Porcaro, Emanuela Fantinel, Riccardo Negrelli, Matteo Ferro, Michele Milella, Matteo Brunelli, Riccardo Autorino, Maria Angela Cerruto, Alessandro Veccia, Alessandro Antonel |
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
Risk of clinically significant prostate cancer after a non-suspicious prostate MRI - a comparison with the general population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 1 . Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas Mirtti, Antti Rannik |
PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Samir Al Bashir, Mohammed S Alorjani, Khalid Kheirallah, Mohammad Al Hamad, Husam K Haddad, Ahmad Al-Dwairy, Baha A Bani-Fawwaz, Najla Aldaoud, Omar Halalsheh, Saddam Amawi, Ismail I Matal |
Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Tomas Januskevicius, Ieva Vaicekauskaite, Rasa Sabaliauskaite, Augustinas Matulevicius, Alvydas Vezelis, Albertas Ulys, Sonata Jarmalaite, Feliksas Jankevici |
Possible prognostic impact of PKC? genetic variants in prostate cancer. Cancer cell international 2024 1 24 (1): 24. Amna Hafeez, Maria Shabbir, Khushbukhat Khan, Janeen H Trembley, Yasmin Badshah, Sameen Zafar, Kanza Shahid, Hania Shah, Naeem Mahmood Ashraf, Arslan Hamid, Tayyaba Afsar, Ali Almajwal, Afifa Marium, Suhail Raz |
Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. Cureus 2024 1 15 (11): e49710. Samar N Ekram, Nasser Al Shanbari, Bassam M Bin Laswad, Abdulrahman Alharthi, Waseem Tayeb, Abdulbari Bah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: